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Of  the  two  epidemics  of  mouse  typhoid  described  by Lynch'  as
occurring  among  the  so  called  cancer  stock  at  The  Rockefeller
Institute,  the first,  or  1918 epidemic  was caused by a strain  of mouse
typhoid  bacillus,  Type  I,  while  the  second,  or  1920  epidemic  was
caused  by a Type II strain.  In commenting  upon this,  Lynch says:
"The  fact  that the  two strains  of the paratyphoid-enteritidis  group,  differing
immunologically from each other and both potentially capable of setting up severe
epidemics  among  mice,  were  responsible  for  the  epidemics  separated  from  each
other  by 2  years,  comes to have  a  special  interest and may possess  a particular
significance  in view of the vaccinations  carried out in the period between the two
epidemics.  For superficially, at least, it appears that the inoculation of the killed
cultures  of the first  bacillus shunted,  as it were,  that particular  organism  out of
action while leaving the recruited population,  both  old and new, and the old even
more  than  the new,  subject to a  second  variety of the mouse  typhoid  bacillus."
Since the last epidemic in 1920, it has become a matter of routine to
administer  subcutaneously  to the  mice  of  this  cancer  stock  a mixed
saline  vaccine  containing both types of mouse  typhoid bacillus,  in an
effort  to  maintain  the  immunity  of  the  population  at  a  level  high
enough  to prevent another  epidemic.  No further outbreak  of mouse
typhoid,  in  anything like  epidemic  proportions,  has  occurred  among
these mice,  although there is known to be a high fecal carrier incidence
of  M.  T.  I  among  them,  and  a slight  carrier  incidence  of  M.  T.  II
also.  Furthermore,  in  a  single  experiment  in  which  twenty-five  of
these  mice,  the  unvaccinated  offspring  of  vaccinated  mothers  and
themselves  free  of  fecal  contamination  with  either  type  of  mouse
'Lynch,  C.  J., J.  Exp. Med.,  1922,  xxxvi,  15.
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typhoid  bacillus,  were employed,  they  showed, when  fed per os with
M. T. II, a corrected  mortality rate  of only  12 per  cent, as compared
to a 64 per  cent mortality among  the  controls.  Practically  no blood
invasion occurred except in those mice which died, although among the
controls blood invasion occurred  at some time in 88 per cent.
Vaccination  with  the strain of M.  T. II employed as  a  stock strain
in  our  laboratory  (the  strain  originally isolated  by Amoss2)  has been
shown  by  Webster 3 to  be  effective  in  protecting  mice  against sub-
sequent  injection  with  living  organisms  of  the  homologous  strain.
Aside from  the vaccination  of the  cancer stock with a mixed  M. T. I
and M.  T. II vaccine,  we had had no experience  with vaccines  made
from  Strain M.  T. I except in the production  of agglutinating sera in
rabbits.  For  this reason  some experiments  were  undertaken  in  the
immunization  of  mice  with vaccines  made from  each  type  of  mouse
typhoid bacillus,  in an attempt  to determine whether  a heterologous
as well  as  a  homologous  protection  was  conferred  by  each  vaccine.
EXPERIMENTAL.
Experiment 1.--Six series  of  twenty-five  mice  each were  assembled  from  the
Rockefeller Institute breeding room, each mouse being placed in a separate battery
jar.  Certain of these mice had received previous vaccination,  as  follows:
Series  A and  F  received  subcutaneously  in  three  successive  weekly  doses  a
monovalent M. T. I vaccine  (1,000,000,000 organisms at each  dose).
Series  C and  D  received  subcutaneously  in  three  successive  weekly  doses  a
monovalent  M. T. II vaccine  (1,000,000,000  organisms  at each  dose).
The six  series of mice were inoculated  by  means  of a  stomach  tube  10  days
after the last vaccination,  as follows:
Series A (M. T. I vaccinated),  0.005 cc. of M. T.  I broth culture per os.
"  B (controls),  0.005  "  "  "  I  "  "  "
"  C  (M. T. II vaccinated),  0.005  "  "  "  I  "  "
t  D (  11II  "  ),0.005  "  "  II  "  C  "
"  E (controls),  0.005  "  "  "  II  "
"  F (M. T. I  vaccinated),  0.005  "  "  "  II  "  "  "  "
The  outcome  of  this  experiment  was  unexpected,  as  shown  by
mortality rates presented in Table I.
2  Amoss, H. L., J. Exp. Med., 1922, xxxvi,  25.
3  Webster, L. T., J. Exp. Med.,  1922,  xxxvi, 71.
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It  appeared  from  these percentages  that a  definite  immunity had
been conferred  by the M. T. II  vaccine against its homologous  strain,
as compared with the natural immunity among the controls, but that
the  M.  T.  I  vaccine,  while  it  had  apparently  modified  slightly  the
form  of  the mortality curve  of  those mice  inoculated per os with  the
homologous  strain, had afforded no more protection against this strain
than  was  conferred  by vaccination  with  the heterologous  M. T.  II,
and  had  failed  to  confer  any  protection  against  the  heterologous
M. T. II  when mice were subsequently inoculated with this organism
per os.
TABLE  I.
Final mortality figures.
Series.
Total.  Corrected.*
per cent  per centa
A  68  64
B  84  84
C  64  52
D  32  24
E  68  64
F  68  64
*Autopsies with negative  blood and  fecal cultures  excluded.
Experiment 2.-A  second  attempt  was  made  to  obtain  a positive  protection
against per os inoculation  of M.  T. I  through  the previous  administration of  an
homologous vaccine.  Owing  to a temporary  shortage  of  mice, smaller  numbers
had to be used and it was impossible to vaccinate a parallel series with M.  T. II,
to repeat  the  experiment  in cross-protection.  The  vaccines employed in Experi-
ment 1 had been made by washing off with saline the 24 hour growth from several
Blake bottles and heating the emulsions thus obtained to 600C. in the water bath
for  1 hour.  In  Experiment  2  a  somewhat  different  technique  was  employed.
The  M. T.  I emulsion  was twice  washed in saline,  after removal  from  the Blake
bottles, and was then killed by heating to 56°C. in a water bath for 1 hour.  It was
hoped  that  the  lower  thermal  death-point  would  kill  the  bacteria  without  too
profoundly altering the bacterial protein.  As a matter of fact, even after heating
for  1 hour at  56°C.,  the vaccine  contained  a very  few  living organisms,  two  or
three colonies developing  when 0.1  cc.  of the undiluted vaccine was smeared  on a
green  dye plate.  Thymol was  added  to the  stock vaccine for  a preservative  as
in Experiment  1.
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In performing this experiment in vaccination with M. T. I, an effort
was  made  to  answer  several  questions:  (a)  Length  of  time  after
vaccination most favorable for per os inoculation with living organisms.
In  an  effort  to  determine  this,  mice  were  inoculated  7  and  14  days
after their last dose  of vaccine.  (b) Number  of doses  most  effective
for  the production  of  immunity.  Some  mice  were  given  two  doses
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TEXT-FIG  1. Scheme used for the vaccination  of  mice with M.  T. I when the
size  of the dose, the number of doses, and the interval  between doses  were varied.
V  indicates  vaccinated; I, inoculated.
of vaccine,  subcutaneously,  and some three.  (c)  The size ofthe dose
capable  of producing  immunity without  proving toxic  to the  mouse.
Half the mice  received, subcutaneously,  doses  of 1,000,000  organisms
each,  and  half  received  doses of 25,000,000 organisms  each.  Events
proved that the smaller dose was not effective,  and the larger dose  too
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toxic to be well  borne.  (d) Intensive as opposed  to gradual vaccina-
tion.  Half  the mice  received  their  doses  of  vaccine  at intervals  of
4 days,  the other half at intervals  of 1 week.
A  scheme  was  worked  out  for the  vaccination  and  inoculation  of
these  mice,  as shown in Text-fig.  1.
Composite  curves,  constructed from  each  series of  mice, according
to large or small dosage of vaccine, together with a composite control
curve,  are  shown  in  Text-fig.  2.  From  these  curves it  will  be  seen
that the mice  receiving  the smaller  doses  of  vaccine  showed,  in the
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TEXT-FIG  2.  Composite  total  mortality  curves  constructed  by  averaging  (a)
all the small dose vaccine series (A'  to H', Text-fig.  1), (b) all the large dose vaccine
series  (A  to H, Text-fig.  1),  and (c)  all the various control  series.
beginning,  a  slight  advantage  over  both  the  controls  and  the  mice
receiving  larger  doses  of  vaccine,  but  that  this  advantage  was  lost
in the period between  15  and  18  days  after inoculation.  Thereafter
the curves  of  the two vaccinated  series ran  an almost parallel  course,
with the small dose series some  10 per cent above the large dose series,
and  the  control  curve  striking  an  almost  exact average  between  the
two,  to the end  of the experimental period.
The  study of  separate  curves gives  little  or  no evidence  that  one
method of vaccine inoculation,  as regards intervals between doses  and
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size  of  doses,  was  preferable  to another,  nor is  there  any  clear-cut
indication  that a  definite  immunity  against  infection  with  M.  T.  I
was conferred by any of the methods of vaccination employed.  That
the antigenic  properties  of the vaccine  were not injured by heat was
indicated by the fact that when injected intravenously into rabbits it
was capable of calling forth the production of an excellent homologous
TABLE  II.
Series.
A
A'
Controls.
B
B'
C
C'
Controls.
D
D'
Controls.
E
E'
F
F'
G
G'
Controls.
H
H'
Controls.
Duration of
experiment.
days
35
35
35
35
35
35
35
35
35
35
35
35
35
35
35
35
35
35
35
35
35
Day last
death
occurred.
29
33
34
31
30
28
33
34
35
31
33
35
30
10
23
34
32
35
11
25
32
No. of mice.
13
14
15
12
14
15
15
13
11
14
15
5
15
8
14
14
14
15
10
13
15
Final mortality figures.
Total.
per cent
86
63
93
81
84
82
82
71
73
100
90
80
100
100
100
77
100
93
70
93
82
Corrected. 
per cent
86
57
93
75
71
73
73
71
64
93
90
80
80
100
93
71
86
87
60
77
82
*Autopsies with negative blood and fecal cultures excluded.
Different  sets of controls had to be used because  separate  groups  of mice  fell
due for inoculation on different days  (Text-fig.  1).
agglutinating  serum.  Mice,  however,  were  unable to respond  to the
inoculations  with the production  of  a demonstrable  active immunity.
The  final  mortality  figures  for  the  different  series  are  given
in Table II.
The  chief  points  of  interest  gained  from  this  experiment  were  as
follows:  (a)  The strain of  M. T. I  used in this laboratory  is far more
￿
l ;
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toxic  than  the  strain  of  M.  T.  II.  It  is  not well  borne,  when  ad-
ministered subcutaneously  to mice as a killed culture, even in doses  as
small  as  25,000,000  organisms.  In  this  experiment,  each  series
originally  included  fifteen  mice.  At  the  time  of  their  inoculation
per os with living organisms,  the original  fifteen  had diminished  con-
siderably,  especially  those  mice  that had  received  the  larger  doses,
as may  be  seen  from  a survey  of  the  numbers  that  finally  came  to
inoculation  (Table  III).
The large  dose appears  to  even greater disadvantage  when further
deductions are made for those mice that died at 24, 48, or 72 hours after
the per os inoculation,  and so had to be discarded  as deaths probably
due  to  accidents  associated  with  the inoculation  (Table II).  There
TABLE  III.
Series.  Large dose  (25,000,000).  Series.  Small dose  (1,000,000).
A  15 mice.  A'  15 mice.
B  14"  B'  15  "
C  15  "  C'  15  "
D  13  "  D'  14  "
E  7  "  E'  15  "
F  9  "  F'  14  "
G  15  "  G'  14  "
H  11  "  H'  14  "
were  ten  such  deaths  among  the  various  series  of  mice  that  had
received the larger doses of vaccine  (25,000,000  organisms),  as against
only  three  among  the  mice  that  had  received  the  smaller  doses
(1,000,000  organisms).  This  may  mean  that  the premature  deaths
were not  wholly  due to accidents  of inoculation, but could be attrib-
uted, at  least  in part, to the lowered resistance  of those animals  that
had received  the larger  doses of vaccine.
(b) This  strain  of  M.  T.  I,  originally  isolated  in  our  laboratory
from  a fatal  case  of  mouse  typhoid,  is not  an  active  antigen for  the
production  of immunity in mice.  A  vaccine  prepared  with it,  even
when administered subcutaneously in two or three doses of 25,000,000
organisms each-doses  large enough  to prove toxic to some animals-
is  incapable  of  producing  a  definite  immunity  against  subsequent
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per os inoculation  with living cultures of M. T. I.  In this respect, as
well  as in its toxicity,  it differs  from  the  M.  T.  II strain isolated  in
this laboratory,  which  possesses more readily  demonstrable  antigenic
properties,  and is  capable,  when  used  as  a  vaccine,  of  conferring  a
definite immunity  against  the homologous  strain,  and possibly  some
slight  cross-protection  against the  M. T. I strain also.
DISCUSSION.
The  effect of  vaccination  with  M.  T. II has  already  been demon-
strated in mice by Webster,3 and by Topley and Wilson4 who designate
their organism  Bacillus enteritidis (aertrycke).  Nichols and  Stimmel5
have recently  described  successful  vaccination  experiments  in guinea
pigs  with a strain  of Bacillus aertrycke (mutton)  derived from  a spon-
taneous  epidemic  among these  animals,  an  organism  which  Webster'
found  to  be  closely  related  to  our  M.  T. II strain.  In  the present
series  of  experiments  also,  M.  T.  II  vaccine  has  been  found  fairly
effective  in  protecting  mice  against  subsequent  per os  inoculation
with  the  homologous  strain.  M.  T.  I  vaccine,  on  the other  hand,
has failed to produce in mice,  under the experimental  conditions  that
existed  here,  any  clearly  demonstrable  immunity  against  its  ho-
mologous  strain  when living  organisms  of  this  strain were  later  ad-
ministered  per os.  The  two  types  of mouse typhoid  bacillus  appear
to  differ  radically  both  in their  toxic properties  and  in their  ability
to act as antigens in mice.
Under  these  circumstances,  a  question  naturally  arises  as  to  the
part played  by  the polyvalent  mouse  typhoid  vaccine  in preventing
an epidemic  of  typhoid,  due to the Type I bacillus, among the cancer
stock  of  The  Rockefeller  Institute.  Since  fecal  carriers  of  M.  T.  I
are fairly numerous  among  these mice,  they are constantly  exposed to
infection from this source,  yet no epidemic due to M. T. I has occurred
among  them  since  1918.  Since  the  M.  T.  II  outbreak  in  1920,  a
certain level of immunity to M. T. II has been artificially maintained
through  vaccination  of  all  young  mice.  The  experiment  in  cross-
4 Topley, W. W.  C., and Wilson, G.  S., J. Llyg.,  1923,  xxi,  243.
5 Nichols, H. J., and Stimmel, C.  O., J. Exp. Med., 1923,  xxxviii,  283.
6 Webster, L. T., J. Exp. Med., 1922, xxxvi, 97.
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protection  indicates  that  some  slight  cross-protection  may  be  con-
ferred  against  per os inoculation  of M.  T. I  by the  administration  of
M. T. II vaccine,  and with the relatively much smaller doses of living
organisms  ingested  by  mice  under  normal  living  conditions,  with
carriers present,  this protection  might  be still  more  effective.  It  is,
of course, possible that the general level of resistance of a mouse popu-
lation  to  infection  with  mouse  typhoid  bacillus  Type  I  might  be
raised  through  long  exposure  to  small  doses  of  living  organisms
excreted  by  carriers  and  ingested  with  food,  even  though  a  killed
vaccine prepared from  this strain is ineffective in producing immunity
on  subcutaneous  inoculation.  It  seems  reasonable  to  assume  that
M. T. II infection in this stock has been kept down by the homologous
strain included  in the  vaccine administered  to  them, but the freedom
of the animals from infection with M. T. I, in the presence of numerous
carriers of  this  organism,  can  scarcely  be  attributed  to  the effects  of
the Type I strain included in the vaccine in view of the negative results
obtained in the vaccination  experiments here recorded.
SUMMARY.
A  saline  vaccine  prepared  from  our  stock  strain  of  M.  T.  II pro-
duces in mice  definite protection  against  the  homologous  strain,  and
perhaps  some  slight  cross-protection  against  M.  T.  I  also.  Two
vaccines  prepared  with  our  stock strain of  M. T. I  failed  to produce
any  definite protection  in  mice  even  against  the  homologous  strain,
nor was  any  cross-protection  afforded  against  M.  T. II.
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